Reply to Cimolai: Post-COVID syndrome and autoimmunity

Yeny Acosta-Ampudia¹, Juan Manuel Anaya^{1

2}

Affiliations

¹ Center for Autoimmune Diseases Research, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
² VaxThera, Bogotá, Colombia.

Editorial

Yeny Acosta-Ampudia et al. J Infect Dis. 2022.

. 2022 Sep 4;226(4):753-754.

doi: 10.1093/infdis/jiac106.

Yeny Acosta-Ampudia¹, Juan Manuel Anaya^{1

2}

¹ Center for Autoimmune Diseases Research, School of Medicine and Health Sciences, Universidad del Rosario, Bogotá, Colombia.
² VaxThera, Bogotá, Colombia.

No abstract available

Comment on

Persistent Autoimmune Activation and Proinflammatory State in Post-Coronavirus Disease 2019 Syndrome.
Acosta-Ampudia Y, Monsalve DM, Rojas M, Rodríguez Y, Zapata E, Ramírez-Santana C, Anaya JM. Acosta-Ampudia Y, et al. J Infect Dis. 2022 Jun 15;225(12):2155-2162. doi: 10.1093/infdis/jiac017. J Infect Dis. 2022. PMID: 35079804 Free PMC article.
Autoantibodies and COVID-19:  Rediscovering Nonspecific Polyclonal B-Cell Activation?
Cimolai N. Cimolai N. J Infect Dis. 2022 Sep 4;226(4):751-752. doi: 10.1093/infdis/jiac105. J Infect Dis. 2022. PMID: 35313338 Free PMC article. No abstract available.